Jump to Navigation
Deciphera

Secondary Menu

  • Home
  • Partners
  • News
  • Contact

Press Release Archives

  • 10.04.2012
    Deciphera Pharmaceuticals Announces Transition to an Oncology Drug Development Company
    Read More
  • 08.29.2012
    Deciphera Pharmaceuticals Announces Approval of rebastinib patent in Japan
    Read More
  • 06.11.2012
    Deciphera Pharmacueticals Announces Appointment of Kapil Bhalla, MD to its Scientific Advisory Board
    Read More
  • 04.26.2012
    Deciphera Pharmaceuticals Announces Appointment of Dr. Patrick O’Connor to its Scientific Advisory Board
    Read More
  • 02.01.2012
    Deciphera Pharmaceuticals Announces Collaboration Milestone with Eli Lilly and Company
    Read More
  • 07.18.2011
    Kansas Biosciences Authority Votes in Favor of a $1.6MM Product Development Grant to Deciphera.
    Read More
  • 07.06.2011
    Deciphera Pharmaceuticals and the University of Kansas Cancer Center team up for clinical study of leukemia drug
    Read More
  • 04.18.2011
    Deciphera Pharmaceuticals Announces DCC-2036 research for CML published in Cancer Cell.
    Read More
  • 01.17.2011
    Deciphera Pharmaceuticals Announces Extension of BRAF collaboration and Receipt of Development Milestone from Eli Lilly and Company.
    Read More
  • 04.07.2009
    Deciphera Pharmaceuticals announces initiation of DCC-2036 Phase 1 Clinical Trial in Refractory CML and All
    Read More
  • 10.03.2008
    KU to lease out vacant lab space for local expansion by Deciphera Pharmaceuticals
    Read More
  • 10.03.2008
    Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
    Read More

Main menu

  • About Us
  • Technology
  • Pipeline
  • Clinical Trials

All News

© 2013 Deciphera Pharmaceuticals, LLC. All Rights Reserved. Site by BOLD.